Lifestyle Intervention for Cardiovascular Disease Risk Factors Among Female Residents at the National Guard Residential City, Jeddah, Saudi Arabia
A Randomized Controlled Trial of Lifestyle Intervention for Cardiovascular Disease Risk Factors Among Female Residents at the National Guard Residential City, Jeddah, Saudi Arabia, 2015
1 other identifier
interventional
85
0 countries
N/A
Brief Summary
Cardiovascular disease (CVD) remains the major cause of mortality globally. Applying a comprehensive interventional program based on the individual's risk may reduce the incidence and complications of CVD; thus, helping to decrease the burden on the healthcare system. This study compared the effects of a 3-month intervention involving lifestyle modification and physical activity with standard care in women ≥30 years having a moderate-to-high risk of CVD, with respect to improving physical activity and cardiovascular disease risk factors at the National Guard Residential City in Jeddah, Saudi Arabia, in 2015. The effects of this community-based lifestyle program were assessed through a randomized controlled trial. Women in the intervention group (n=31) received health education, exercise training, and diet counselling as individuals and in groups according to the participant's risk. Women in the control group (n=28) received one health education session at the screening site. The Framingham risk score (FRS) was calculated at baseline and at 3 months for both groups. The mean participant age was 42±8 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cardiovascular-diseases
Started Jan 2015
Shorter than P25 for not_applicable cardiovascular-diseases
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 6, 2017
CompletedFirst Posted
Study publicly available on registry
May 22, 2018
CompletedNovember 6, 2019
November 1, 2019
7 months
December 6, 2017
November 4, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Framingham Risk Scores Reduction
The proportion of individuals with moderate Framingham risk scores (FRS) reducing their risk by 10% and the proportion of individuals with high (FRS) reducing their risk by 25% using the Framingham risk score. It consists of six point scores including age, total cholesterol, smoking status, HDL level, diabetes status, systolic Blood Pressure and Treatment Status. The sum of these points will result in an estimate of the 10-Year risk of developing cardiovascular event and for risk categorization of low (\< 10% FRS), moderate (10%-19% FRS), or high risk (≥ 20% FRS).
3 months
Secondary Outcomes (1)
Framingham Risk Category Changes
3 months
Study Arms (2)
Lifestyle Modification group
ACTIVE COMPARATORControl group
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Women aged ≥ 30 years.
- The participants must be at moderate to high-risk of CVD according to FRS.
You may not qualify if:
- Women aged \< 30 years.
- Women aged ≥ 30 years with low risk of CVD according to FRS.
- Pregnant women.
- Female patients diagnosed with CVD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Cox JL, Vallis TM, Pfammatter A, Szpilfogel C, Carr B, O'Neill BJ. A novel approach to cardiovascular health by optimizing risk management (ANCHOR): behavioural modification in primary care effectively reduces global risk. Can J Cardiol. 2013 Nov;29(11):1400-7. doi: 10.1016/j.cjca.2013.03.007. Epub 2013 Jun 21.
PMID: 23796526RESULT
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Jumana Khouja, MD, SBCM
KAIMRC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Consultant
Study Record Dates
First Submitted
December 6, 2017
First Posted
May 22, 2018
Study Start
January 1, 2015
Primary Completion
August 1, 2015
Study Completion
September 1, 2015
Last Updated
November 6, 2019
Record last verified: 2019-11